Please ensure Javascript is enabled for purposes of website accessibility

Why Doximity Stock Surged on Monday

By Danny Vena – Aug 23, 2021 at 4:29PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The networking and productivity platform for doctors is riding a wave of positive investor sentiment.

What happened

Shares of Doximity (DOCS 1.39%) traded higher on Monday, climbing as high as 14.8% on growing enthusiasm from investors, though the stock ended the trading session up 14%. The cloud-based service for doctors and other healthcare professionals climbed on no specific news, but has been riding a wave of positive sentiment that began with its first financial report as a public company. All told, the stock has gained more than 60% since its earnings release on Aug. 10. 

So what

For its fiscal 2022 first quarter (which ended June 30), Doximity generated revenue of $72.7 million, up 100% year over year, accelerating from full-year growth of 36% and 78% in fiscal 2020 and 2021, respectively. The company also delivered earnings per share of $0.09, up from breakeven in the prior-year quarter.

Doctor speaking to a patient and both are wearing masks.

Image source: Getty Images.

Doximity also got a boost as the result of positive comments made by CNBC's Jim Cramer. The television personality and former hedge fund manager said investors "definitely" should buy shares of Doximity, calling it "a star" and "the best of the best."

"Their EBITDA [earnings before interest, taxes, depreciation, and amortization] margin came in at 43%," Cramer added. "Analysts were only looking for 30%. That's extraordinary." 

Now what

Investors are also celebrating Doximity's robust guidance for its fiscal Q2 and the full year. The company forecast revenue of $73.5 million at the midpoint of its guidance, sailing past analysts' consensus estimates of $71.8 million. Additionally, for the 2022 fiscal year, Doximity is guiding for revenue between $296.5 million and $299.5 million, ahead of analysts' expectations of $295.5 million. 

The company's accelerating revenue, growing profits, and positive analyst commentary have investors psyched about its prospects.

Danny Vena has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Doximity, Inc. Stock Quote
Doximity, Inc.
DOCS
$32.15 (1.39%) $0.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.